Imprimer
Votre recherche pour:
11 229 les résultats ont été trouvés
Protéines et Peptides
Numéro de catalogue:
(PRSI4883P)
Fournisseur:
ProSci Inc.
Description:
Disp2 peptide is used for blocking the activity of Disp2 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI4207P)
Fournisseur:
ProSci Inc.
Description:
TSLP receptor peptide is used for blocking the activity of TSLP receptor antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI6451P)
Fournisseur:
ProSci Inc.
Description:
Coronin 7 peptide is used for blocking the activity of Coronin 7 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI6439P)
Fournisseur:
ProSci Inc.
Description:
L1TD1 peptide is used for blocking the activity of L1TD1 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI6453P)
Fournisseur:
ProSci Inc.
Description:
TMEM147 peptide is used for blocking the activity of TMEM147 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI7013P)
Fournisseur:
ProSci Inc.
Description:
TET3 peptide is used for blocking the activity of TET3 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI4249P)
Fournisseur:
ProSci Inc.
Description:
SLPI peptide is used for blocking the activity of SLPI antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI4243P)
Fournisseur:
ProSci Inc.
Description:
IFN-beta peptide is used for blocking the activity of IFN-b antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI91-852)
Fournisseur:
ProSci Inc.
Description:
Complement factor H-related protein 5(FHR-5 for short), is a secreted protein which contains 9 Sushi (CCP/SCR) domains. It is expressed by the liver and secreted in plasma. The pattern of the deposits is similar to other complement components, suggesting that FHR-5 may play a role in complement activation and regulation. Defects in CFHR5 have been found in patients with atypical hemolytic uremic syndrome and may contribute to the disease. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI91-856)
Fournisseur:
ProSci Inc.
Description:
Vasoactive intestinal peptide is also known as the vasoactive intestinal polypeptide or VIP. In humans, it is encoded by the VIP gene. VIP is neuropeptide which belongs to a glucagon/secretin superfamily, the ligand of class II G protein-coupled receptors. VIP is produced in many tissues of vertebrates including the gut, pancreas and suprachiasmatic nuclei of the hypothalamus in the brain. VIP stimulates contractility in the heart, causes vasodilation, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. VIP has a half-life (t½) in the blood of about two minutes.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI96-350)
Fournisseur:
ProSci Inc.
Description:
Growth hormone receptor (GHR) is also known as somatotropin receptor, growth hormone-binding protein (GHBR), which belongs to the type I cytokine receptor family or Type 1 subfamily. GHR contains one fibronectin type-III domain. GHR / GHBR is expressed in various tissues with high expression in liver and skeletal muscle. The soluble form (GHBP) is produced by phorbol ester-promoted proteolytic cleavage at the cell surface (shedding) by ADAM17/TACE. GHR is receptor for pituitary gland growth hormone involved in regulating postnatal body growth. On ligand binding, couples to the JAK2/STAT5 pathway. The soluble form (GHBP) acts as a reservoir of growth hormone in plasma and may be a modulator/inhibitor of GH signaling.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI91-340)
Fournisseur:
ProSci Inc.
Description:
Leukocyte-Associated Immunoglobulin-Like Receptor 2 (LAIR2) is a secreted, 131 amino acid protein that contains one Ig-like C2 type domain, making it a member of the Ig superfamily. When compared to LAIR-1, its transmembrane counterpart, it shares 83% amino acid identity across the signal sequence and extracellular domains; although one is secreted and one is membrane-bound, the two LAIR proteins are thought to have arisen from a common gene ancestor and appear to share similar adhesion profiles. This suggests that LAIR-2 may compete with LAIR-1 for ligand binding. A 114 amino acid alternate splice form of LAIR-2 is truncated at the C terminus, but retains the entire Ig domain. The expression profile of these splice forms, and the presence of orthologs in other species, have not been reported.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI5235P)
Fournisseur:
ProSci Inc.
Description:
Seasonal H1N1 Hemagglutinin peptide is meant to be used as a positive control in ELISA applications to detect Seasonal Influenza A antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI5219P)
Fournisseur:
ProSci Inc.
Description:
MIPU1 peptide is used for blocking the activity of MIPU1 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI5221P)
Fournisseur:
ProSci Inc.
Description:
AFAP1L2 peptide is used for blocking the activity of AFAP1L2 antibody.
UOM:
1 * 50 µG
Numéro de catalogue:
(PRSI96-356)
Fournisseur:
ProSci Inc.
Description:
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy.
UOM:
1 * 20 µG
Appel de prix
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'
 est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'
est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Ces articles ne peuvent être ajoutés au Panier. Veuillez contacter votre service client ou envoyer un e-mail à vwr.be@vwr.com
Une documentation supplémentaire peut être nécessaire pour l'achat de cet article. Un représentant de VWR vous contactera si nécessaire.
Ce produit a été bloqué par votre organisation. Contacter votre service d'achat pour plus d'informations.
Le produit original n'est plus disponible. Le remplacement représenté est disponible
Les produits marqués de ce symbole ne seront bientôt plus disponibles - vente jusqu'à épuisement de stock. Des alternatives peuvent être disponibles en recherchant le code article VWR indiqué ci-dessus. Si vous avez besoin d'une assistance supplémentaire, veuillez contacter notre Service Clientèle au 016 385 011.
|
|||||||||
Vue liste
